FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use
After hours: If urgent, life threatening (please call 988, 911, or go to nearest ER. Otherwise, for side effects to medications, please text 816-766-0119. For all other non-urgent issues, please contact us Practice Q messaging portal or contact us during clinic hours at 888-855-0947.
Ready for your Mental Health Transformation?
Child Psychiatrist /Adult Psychiatrist
Blog
Early Sleep Improvement and Response to Pharmacotherapy in Psychotic Depression
Orexin: The New Kid on the Insomnia Block
Appropriate Use of Stimulant Medications in Adults With ADHD
Lag in Antidepressant Treatment Response Explained?
GLP-1 Agonists and Suicide Risk: What Action Should Be Taken?
Esketamine Bests Quetiapine for Severe Depression in Head-to-Head Trial
Ketamine No Better for Depression Than Placebo?
FDA Clears First OTC Fentanyl Urine Test
Looking for a Psychiatrist that takes your Insurance?
Confirmed: Intermittent Use of Benzodiazepines Is the Safest Option
Study Finds Esketamine Nasal Spray More Likely to Induce Remission in Treatment-Resistant MDD Than Q
The Making of Adult ADHD: The Rapid Rise of a Novel Psychiatric Diagnosis
Providing Hope During National Suicide Prevention Month
Fentanyl Laced Stimulants Fuel Opioid Crisis' Fourth Wave
Gabapentin May Not Reduce Opioid Use in Chronic Opioid Users
FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD
“Talk. They Hear You.” Celebrates 10 Years of Preventing Underage Substance Use
Study Says Casual Pot Use Harmful to Teens
Are Ketogenic Supplements the Key to Healthy Aging?